Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
Yoshiteru Ohata(Tokyo Medical and Dental University), Shinji Tanaka(Tokyo Institute of Technology), Keisuke Nakao(Central Research Institute of Electric Power Industry), Yusuke Mitsunori(Tokyo Medical and Dental University), Arihiro Aihara(Tokyo Medical and Dental University), Kaoru Mogushi(Juntendo University), Shu Shimada(Tokyo Medical and Dental University), Satoshi Matsumura(Saitama University), Minoru Tanabe(Tokyo Institute of Technology), Atsushi Kudo(Tokyo Medical and Dental University), Takanori Ochiai(Tokyo Medical and Dental University), Yoshimitsu Akiyama(Tokyo Medical and Dental University), Shigeki Arii(Kyoto University), Daisuke Ban(Tokyo Medical and Dental University)
Cited by 45
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study
|The Lancet Neurology|2015|359
In-Orbit Performance of the Hard X-Ray Detector on Board Suzaku
|Publications of the Astronomical Society of Japan|2007|334
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277